Veteran Biotech Software Company Changes Business Name

CARLSBAD, Calif., July 15, 2020 (Newswire.com) - Brendan Technologies, Inc., a biotech software company based in Carlsbad, California, has announced that it will now operate under the registered DBA (doing business as) name of Brendan Bioanalytics. 

The change was made to better align the company’s name with its products and services offered through its flagship software, STATLIA^®.

“The analytics we provide for the technologies we address have always been one of our software’s core capabilities,” said John R. Dunn II, Ph.D., CEO of Brendan Bioanalytics. “Our STATLIA software does much more than analyze assays, but the analytics are still an important hallmark of our company.”

The name change to Brendan Bioanalytics was made in advance of the release of the company’s new software, STATLIA MATRIX 5.0. The software provides advanced analysis and enterprise workflow capabilities for regulated biopharmaceutical laboratories for the following technologies:

• ELISA Software Analysis
• Relative Potency Assays
  • Chi-Square Method for Parallelism
  • Equivalence Method for Parallelism
• Immunogenicity Assays

Brendan Bioanalytics will retain the legal incorporated name Brendan Technologies, Inc.  The tax identification number, company address, email addresses, phone numbers, and website URL www.brendan.com will all remain unchanged.

About Brendan Bioanalytics

Brendan Bioanalytics develops advanced analysis and enterprise workflow software for developing, validating, running and monitoring ELISA, relative potency, and immunogenicity assay technologies in regulated biopharmaceutical laboratories.

Formed in 1997, Brendan Bioanalytics has introduced several innovative methods in its software to advance the accuracy, reliability, and analytical metrics for 5PL Curve Fitting, curve weighting, Chi-Square Method for parallelism assays, and other analytical processes.  The company’s manuscripts on 5PL Curve Fitting, The Five Parameter Logistic: A Characterization And Comparison With The Four Parameter Logistic, and Relative Potency Assays, Measuring Parallelism, Linearity and Relative Potency in Immunoassay and Bioassay Data, have been cited more than 400 times.

STATLIA is a registered trademark of Brendan Bioanalytics.
© 2020 Brendan Bioanalytics. All Rights Reserved.

Source: Brendan Bioanalytics